The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.
The National Genomic Test Directory is hosted on the NHS England website
Included is the:
- National Genomic Test Directory for Rare and Inherited Disease
- Rare and Inherited Disease Eligibility Criteria
- National Genomic Test Directory for Cancer
Please be advised to always use the live versions of the National Genomic Test Directory.
The latest update to the National Genomic Test Directory was made live on the NHS England website on 12 May 2023. It was published to align with the National Institute for Health and Care Excellence recommendations on Olaparib in breast and prostate cancers.
The expectation is that each GLH will work to deliver the updated test directory within three months of publication. Thank you in advance for your patience with the Genomic Medicine Service as these updates are made operational across the country.
Test Directory updates
Timescales for updates to the National Genomic Test Directory after April 2023 are being defined.
Application forms for future updates can be downloaded here
Publication of the Test Directory
If you have any questions regarding this information then please email england.testevaluation@nhs.net